SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-157825
Filing Date
2023-05-31
Accepted
2023-05-31 16:07:59
Documents
12
Period of Report
2023-05-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d510579d8k.htm   iXBRL 8-K 22493
  Complete submission text file 0001193125-23-157825.txt   143421

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA evlo-20230530.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE evlo-20230530_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evlo-20230530_pre.xml EX-101.PRE 11253
6 EXTRACTED XBRL INSTANCE DOCUMENT d510579d8k_htm.xml XML 3345
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 23981068
SIC: 2834 Pharmaceutical Preparations